Footer

    Edwyn
    Edwyn

    Conduct a professional comparative analysis in seconds. Empowering your financial decisions with data-driven insights.

    Subscribe to our newsletter

    The latest financial trends, sent to your inbox weekly.

    Products

    • Stock Comparisons
    • Enterprise Value Tool
    • EDGAR Database

    Guides

    • What is Enterprise Value?
    • How much is my company worth?

    Company

    • About
    • Contact us
    • Register

    Legal

    • Privacy
    • Terms

    © Edwyn, LLC. All rights reserved.

    Edwyn logo

    Edwyn

    Contact usWhat is Enterprise Value?Advanced EV Calculator
    UNITEDHEALTH GROUP INC (UNH)
    Add to EV Report
    Compare UNH
    Income
    Balance Sheet
    Edwyn logo

    Edwyn

    Tesla vs GMApple vs MicrosoftNvidia vs AMD
    NVDATSLAAAPL
    EV Demo
    Log in
    Edwyn logo

    Edwyn

    Find Companies
    Find Companies
    EV ReportCompare Stocks
    Companies, tickers…⌘ K
    Try EV demoCompare Stocks
    Log in
    Tesla vs GMApple vs MicrosoftNvidia vs AMD
    EV Demo
    NVDATSLAAAPL
    Log in to save
    Latest price
    $284.18
    -0.49%
    Dollar Amounts
    USD (Millions)
    Metric20212022202320242025
    Assets$212,206$245,705$273,720$298,278N/A
    Liabilities$135,727$159,358$174,801$195,687N/A
    Equity$75,045$81,450$94,421$98,268N/A
    Data source10-K10-K10-K10-K10-K
    Balance sheet data in USD (millions)
    Doing some research...

    Commentary on UNITEDHEALTH GROUP INCORPORATED Balance Sheet

    From 2021 through 2024 UnitedHealth’s balance sheet shows clear scale-up: total assets rose from $212,206m to $298,278m (≈+40.6%), while total liabilities increased from $135,727m to $195,687m (≈+44.2%). Stockholders’ equity grew from $75,045m to $98,268m (≈+31.0%). Year-to-year, 2022 saw a notable step-up in assets and liabilities, 2023 delivered the strongest equity advance (equity +15.9% year-over-year), and 2024 continued asset growth but with liabilities (≈+12.0%) outpacing equity (≈+2.0%), which materially slowed equity accumulation. The balance-sheet mix implies a modest rise in leverage: the equity-to-assets ratio slipped from about 35.4% (2021) to ~33.0% (2024), and liabilities-to-equity moved from ~1.81x to ~1.99x. That pattern is consistent with scaling operations in the managed-care/health services industry where premium volume, claim reserves and financing for strategic investments or acquisitions can push both assets and liabilities higher; the 2024 slowdown in equity growth suggests more of the balance-sheet expansion was debt- or liability-driven. Note the 2025 row contains zeros and appears to be missing data; based on 2021–2024 trends, management and investors should watch claims reserves, debt levels and capital generation (earnings/stock actions) to ensure leverage stays within target ranges.

    This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.